Restless Legs Drugs Need Black Box Warnings, FDA Hears

Several drugs for restless legs syndrome should get black box warnings that emphasize the risks of impulse-control disorders and other side effects, an industry-backed research company told the U.S. Food and...

Already a subscriber? Click here to view full article